Biomarin Pharmaceutical Inc (BMRN)

Net profit margin

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Net income (ttm)	US$ in thousands	205,455	167,645	147,021	99,991	71,615	141,561	83,912	54,070	39,347	-64,080	10,846	832,143	790,019	854,029	852,025	122,258	114,006	-23,848	-42,522	-110,178
Revenue (ttm)	US$ in thousands	2,443,023	2,373,030	2,261,604	2,184,719	2,123,138	2,059,481	1,999,471	1,903,678	1,871,615	1,827,451	1,829,463	1,891,778	1,815,339	1,822,817	1,822,364	1,813,337	1,772,797	1,694,305	1,597,556	1,518,971
Net profit margin		8.41%	7.06%	6.50%	4.58%	3.37%	6.87%	4.20%	2.84%	2.10%	-3.51%	0.59%	43.99%	43.52%	46.85%	46.75%	6.74%	6.43%	-1.41%	-2.66%	-7.25%

March 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $205,455K ÷ $2,443,023K
= 8.41%

The net profit margin of Biomarin Pharmaceutical Inc has shown varying trends over the past few quarters. From March 31, 2019, to March 31, 2024, the net profit margin has fluctuated between negative values to as high as 8.41%. There was a significant improvement in the net profit margin from negative values in 2021 to positive values in 2022 and 2023, reaching a peak of 8.41% in March 31, 2024. This improvement indicates that the company's efficiency in generating profit from its revenue has been on an upward trajectory in recent quarters.